Adding Serplulimab to Chemotherapy Improves Survival in Squamous NSCLC
First-line treatment with serplulimab plus chemotherapy improves survival over chemotherapy alone in patients with advanced squamous NSCLC, a phase 3 trial suggests.
First-line treatment with serplulimab plus chemotherapy improves survival over chemotherapy alone in patients with advanced squamous NSCLC, a phase 3 trial suggests.
New research suggests that genetic susceptibility to lung cancer is greater in women, and a family history of cancer predicts lung cancer risk.
Malnutrition was associated with cancer stage and geriatric symptoms in older women with breast cancer, according to a recent study.
An analysis of oncology nurse-led research revealed common topics, as well as direction toward areas that merit further investigation.
Aromatherapy at the end of life improved cancer-related pain and opioid use in patients with cancer, according to a recent study.
A survey study identified the workplace characteristics that encourage nurses to speak up on behalf of patient safety and quality of care.
Researchers investigated the association between preexisting interstitial lung abnormalities and immune checkpoint inhibitor-related pneumonitis.
Patient decision aids proved to be useful to patients with cancer in exploring first-line treatment options, according to an analysis.
A study determined oncology nurses are aware of biomarker testing and targeted therapy for ovarian cancer but seemed less aware of their specific details.
Multiple risk factors and impacts were noted in a review examining financial toxicity in patients with breast cancer.